The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Quetiapine Fumarate-Global Market Insights and Sales Trends 2025
Synopsis
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
The global Quetiapine Fumarate market size is expected to reach US$ 136.4 million by 2029, growing at a CAGR of -2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Quetiapine Fumarate in various end use industries. The expanding demands from the Adult and Others, are propelling Quetiapine Fumarate market. Immediate Release Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Extended Release Tablets segment is estimated at % CAGR for the next seven-year period.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Quetiapine Fumarate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Quetiapine Fumarate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Quetiapine Fumarate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Quetiapine Fumarate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Quetiapine Fumarate covered in this report include AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical and Hunan Dongting Pharm, etc.
The global Quetiapine Fumarate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Global Quetiapine Fumarate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Quetiapine Fumarate market, Segment by Type:
Immediate Release Tablets
Extended Release Tablets
Global Quetiapine Fumarate market, by Application
Adult
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Quetiapine Fumarate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
The global Quetiapine Fumarate market size is expected to reach US$ 136.4 million by 2029, growing at a CAGR of -2.2% from 2023 to 2029. The market is mainly driven by the significant applications of Quetiapine Fumarate in various end use industries. The expanding demands from the Adult and Others, are propelling Quetiapine Fumarate market. Immediate Release Tablets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Extended Release Tablets segment is estimated at % CAGR for the next seven-year period.
Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.
The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Quetiapine Fumarate, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Quetiapine Fumarate market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Quetiapine Fumarate market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Quetiapine Fumarate sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Quetiapine Fumarate covered in this report include AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical and Hunan Dongting Pharm, etc.
The global Quetiapine Fumarate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Intas
TAPI
Accord
Hexal
Dr.Reddy's
Lupin
Sun Pharmaceutical
Hunan Dongting Pharm
SuZhou NO.4 Phamaceutical Factory
Fuan Pharmaceutical
Zhejiang Supor Pharmaceuticals
Zhejiang Huahai Pharmaceutical
Global Quetiapine Fumarate market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Quetiapine Fumarate market, Segment by Type:
Immediate Release Tablets
Extended Release Tablets
Global Quetiapine Fumarate market, by Application
Adult
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Quetiapine Fumarate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Quetiapine Fumarate Market Overview
1.1 Quetiapine Fumarate Product Overview
1.2 Quetiapine Fumarate Market Segment by Type
1.2.1 Immediate Release Tablets
1.2.2 Extended Release Tablets
1.3 Global Quetiapine Fumarate Market Size by Type
1.3.1 Global Quetiapine Fumarate Market Size Overview by Type (2018-2029)
1.3.2 Global Quetiapine Fumarate Historic Market Size Review by Type (2018-2023)
1.3.3 Global Quetiapine Fumarate Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Quetiapine Fumarate Sales Breakdown by Type (2018-2023)
1.4.2 Europe Quetiapine Fumarate Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Quetiapine Fumarate Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Quetiapine Fumarate Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Quetiapine Fumarate Sales Breakdown by Type (2018-2023)
2 Global Quetiapine Fumarate Market Competition by Company
2.1 Global Top Players by Quetiapine Fumarate Sales (2018-2023)
2.2 Global Top Players by Quetiapine Fumarate Revenue (2018-2023)
2.3 Global Top Players by Quetiapine Fumarate Price (2018-2023)
2.4 Global Top Manufacturers Quetiapine Fumarate Manufacturing Base Distribution, Sales Area, Product Type
2.5 Quetiapine Fumarate Market Competitive Situation and Trends
2.5.1 Quetiapine Fumarate Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Quetiapine Fumarate Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Quetiapine Fumarate as of 2022)
2.7 Date of Key Manufacturers Enter into Quetiapine Fumarate Market
2.8 Key Manufacturers Quetiapine Fumarate Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Quetiapine Fumarate Status and Outlook by Region
3.1 Global Quetiapine Fumarate Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Quetiapine Fumarate Historic Market Size by Region
3.2.1 Global Quetiapine Fumarate Sales in Volume by Region (2018-2023)
3.2.2 Global Quetiapine Fumarate Sales in Value by Region (2018-2023)
3.2.3 Global Quetiapine Fumarate Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Quetiapine Fumarate Forecasted Market Size by Region
3.3.1 Global Quetiapine Fumarate Sales in Volume by Region (2024-2029)
3.3.2 Global Quetiapine Fumarate Sales in Value by Region (2024-2029)
3.3.3 Global Quetiapine Fumarate Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Quetiapine Fumarate by Application
4.1 Quetiapine Fumarate Market Segment by Application
4.1.1 Adult
4.1.2 Others
4.2 Global Quetiapine Fumarate Market Size by Application
4.2.1 Global Quetiapine Fumarate Market Size Overview by Application (2018-2029)
4.2.2 Global Quetiapine Fumarate Historic Market Size Review by Application (2018-2023)
4.2.3 Global Quetiapine Fumarate Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Quetiapine Fumarate Sales Breakdown by Application (2018-2023)
4.3.2 Europe Quetiapine Fumarate Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Quetiapine Fumarate Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Quetiapine Fumarate Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Quetiapine Fumarate Sales Breakdown by Application (2018-2023)
5 North America Quetiapine Fumarate by Country
5.1 North America Quetiapine Fumarate Historic Market Size by Country
5.1.1 North America Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Quetiapine Fumarate Sales in Volume by Country (2018-2023)
5.1.3 North America Quetiapine Fumarate Sales in Value by Country (2018-2023)
5.2 North America Quetiapine Fumarate Forecasted Market Size by Country
5.2.1 North America Quetiapine Fumarate Sales in Volume by Country (2024-2029)
5.2.2 North America Quetiapine Fumarate Sales in Value by Country (2024-2029)
6 Europe Quetiapine Fumarate by Country
6.1 Europe Quetiapine Fumarate Historic Market Size by Country
6.1.1 Europe Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Quetiapine Fumarate Sales in Volume by Country (2018-2023)
6.1.3 Europe Quetiapine Fumarate Sales in Value by Country (2018-2023)
6.2 Europe Quetiapine Fumarate Forecasted Market Size by Country
6.2.1 Europe Quetiapine Fumarate Sales in Volume by Country (2024-2029)
6.2.2 Europe Quetiapine Fumarate Sales in Value by Country (2024-2029)
7 Asia-Pacific Quetiapine Fumarate by Region
7.1 Asia-Pacific Quetiapine Fumarate Historic Market Size by Region
7.1.1 Asia-Pacific Quetiapine Fumarate Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Quetiapine Fumarate Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Quetiapine Fumarate Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Quetiapine Fumarate Forecasted Market Size by Region
7.2.1 Asia-Pacific Quetiapine Fumarate Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Quetiapine Fumarate Sales in Value by Region (2024-2029)
8 Latin America Quetiapine Fumarate by Country
8.1 Latin America Quetiapine Fumarate Historic Market Size by Country
8.1.1 Latin America Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Quetiapine Fumarate Sales in Volume by Country (2018-2023)
8.1.3 Latin America Quetiapine Fumarate Sales in Value by Country (2018-2023)
8.2 Latin America Quetiapine Fumarate Forecasted Market Size by Country
8.2.1 Latin America Quetiapine Fumarate Sales in Volume by Country (2024-2029)
8.2.2 Latin America Quetiapine Fumarate Sales in Value by Country (2024-2029)
9 Middle East and Africa Quetiapine Fumarate by Country
9.1 Middle East and Africa Quetiapine Fumarate Historic Market Size by Country
9.1.1 Middle East and Africa Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Quetiapine Fumarate Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Quetiapine Fumarate Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Quetiapine Fumarate Forecasted Market Size by Country
9.2.1 Middle East and Africa Quetiapine Fumarate Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Quetiapine Fumarate Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca Quetiapine Fumarate Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Intas
10.2.1 Intas Company Information
10.2.2 Intas Introduction and Business Overview
10.2.3 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Intas Quetiapine Fumarate Products Offered
10.2.5 Intas Recent Development
10.3 TAPI
10.3.1 TAPI Company Information
10.3.2 TAPI Introduction and Business Overview
10.3.3 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.3.4 TAPI Quetiapine Fumarate Products Offered
10.3.5 TAPI Recent Development
10.4 Accord
10.4.1 Accord Company Information
10.4.2 Accord Introduction and Business Overview
10.4.3 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Accord Quetiapine Fumarate Products Offered
10.4.5 Accord Recent Development
10.5 Hexal
10.5.1 Hexal Company Information
10.5.2 Hexal Introduction and Business Overview
10.5.3 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hexal Quetiapine Fumarate Products Offered
10.5.5 Hexal Recent Development
10.6 Dr.Reddy's
10.6.1 Dr.Reddy's Company Information
10.6.2 Dr.Reddy's Introduction and Business Overview
10.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Dr.Reddy's Quetiapine Fumarate Products Offered
10.6.5 Dr.Reddy's Recent Development
10.7 Lupin
10.7.1 Lupin Company Information
10.7.2 Lupin Introduction and Business Overview
10.7.3 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Lupin Quetiapine Fumarate Products Offered
10.7.5 Lupin Recent Development
10.8 Sun Pharmaceutical
10.8.1 Sun Pharmaceutical Company Information
10.8.2 Sun Pharmaceutical Introduction and Business Overview
10.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sun Pharmaceutical Quetiapine Fumarate Products Offered
10.8.5 Sun Pharmaceutical Recent Development
10.9 Hunan Dongting Pharm
10.9.1 Hunan Dongting Pharm Company Information
10.9.2 Hunan Dongting Pharm Introduction and Business Overview
10.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Hunan Dongting Pharm Quetiapine Fumarate Products Offered
10.9.5 Hunan Dongting Pharm Recent Development
10.10 SuZhou NO.4 Phamaceutical Factory
10.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
10.10.2 SuZhou NO.4 Phamaceutical Factory Introduction and Business Overview
10.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Products Offered
10.10.5 SuZhou NO.4 Phamaceutical Factory Recent Development
10.11 Fuan Pharmaceutical
10.11.1 Fuan Pharmaceutical Company Information
10.11.2 Fuan Pharmaceutical Introduction and Business Overview
10.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Fuan Pharmaceutical Quetiapine Fumarate Products Offered
10.11.5 Fuan Pharmaceutical Recent Development
10.12 Zhejiang Supor Pharmaceuticals
10.12.1 Zhejiang Supor Pharmaceuticals Company Information
10.12.2 Zhejiang Supor Pharmaceuticals Introduction and Business Overview
10.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Products Offered
10.12.5 Zhejiang Supor Pharmaceuticals Recent Development
10.13 Zhejiang Huahai Pharmaceutical
10.13.1 Zhejiang Huahai Pharmaceutical Company Information
10.13.2 Zhejiang Huahai Pharmaceutical Introduction and Business Overview
10.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Products Offered
10.13.5 Zhejiang Huahai Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Quetiapine Fumarate Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Quetiapine Fumarate Industrial Chain Analysis
11.4 Quetiapine Fumarate Market Dynamics
11.4.1 Quetiapine Fumarate Industry Trends
11.4.2 Quetiapine Fumarate Market Drivers
11.4.3 Quetiapine Fumarate Market Challenges
11.4.4 Quetiapine Fumarate Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Quetiapine Fumarate Distributors
12.3 Quetiapine Fumarate Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
